Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus retinitis.

類似資料

• Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
  著者:: Jacobson, M A, 等
  出版事項: (1989)
• Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.
  著者:: Aweeka, F, 等
  出版事項: (1989)
• Combined ganciclovir and foscarnet in pediatric cytomegalovirus retinitis.
  著者:: Sastry, S. M., 等
  出版事項: (1996)
• High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS.
  著者:: Diaz-Llopis, M, 等
  出版事項: (1994)
• Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
  著者:: Ganly, P. S., 等
  出版事項: (1988)